Overview Financials News + Filings Key Docs Charts Holdings Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Inv. presentation
Quarterly results
Director departure
Appointed director
|
|
Acer Therapeutics Inc. (ACER)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 02/14/2023 |
SC 13G/A
| Nantahala Capital Management, LLC reports a 7.5% stake in Acer Therapeutics Inc. |
| 02/14/2022 |
SC 13G/A
| Nantahala Capital Management, LLC reports a 6.3% stake in Acer Therapeutics Inc. |
| 02/12/2021 |
SC 13G/A
| Nantahala Capital Management, LLC reports a 8.1% stake in Acer Therapeutics Inc. |
| 08/06/2020 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/13/2020 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/12/2020 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/14/2019 |
SC 13G/A
| Vivo Opportunity, LLC reports a 5.8% stake in Acer Therapeutics Inc. |
| 02/05/2016 |
SC 13G/A
| Anson Funds Management LP reports a 0.3% stake in Opexa Therapeutics, Inc. |
| 09/03/2014 |
SC 13G/A
| SHEEDY CHARLES E reports a 1.9% stake in Opexa Therapeutics, Inc. |
| 02/13/2014 |
SC 13G/A
| CAPITAL VENTURES INTERNATIONAL reports a 0% stake in Opexa Therapeutics, Inc. |
| 01/08/2014 |
SC 13G/A
| SABBY MANAGEMENT, LLC reports a 1.6% stake in Opexa Therapeutics, Inc. |
| 02/14/2013 |
SC 13G/A
| Lehman Brothers Holdings Inc. reports a 0% stake in Opexa Therapeutics, Inc. |
| 02/14/2013 |
SC 13G/A
| Visium Asset Management, LP reports a 1.5% stake in Opexa Therapeutics, Inc. |
| 02/13/2013 |
SC 13G/A
| SHEEDY CHARLES E reports a 7.6% stake in Opexa Therapeutics, Inc. |
| 02/10/2012 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/11/2011 |
SC 13G/A
| SHEEDY CHARLES E reports a 7.9% stake in Opexa Therapeutics, Inc. |
| 10/12/2010 |
SC 13G/A
| Opexa Therapeutics, Inc. reports a 4.5% stake in Opexa Therapeutics, Inc. |
| 02/16/2010 |
SC 13G/A
| Opexa Therapeutics, Inc. reports a 11% stake in Opexa Therapeutics, Inc. |
| 07/23/2009 |
SC 13G/A
| SHEEDY CHARLES E reports a 10.6% stake in Opexa Therapeutics, Inc. |
| 02/17/2009 |
SC 13G/A
| Form SC 13G/A -- Statement of acquisition of beneficial ownership by individuals [amend] |
|
|